Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Lane, AM"" wg kryterium: Autor


Tytuł :
Conservative management of suspicious melanocytic lesions of the iris.
Autorzy :
Oxenreiter MM; Ocular Melanoma Center, Retina Service, Mass Eye and Ear, 243 Charles Street., Boston, MA, 02114, USA.
Lane AM; Ocular Melanoma Center, Retina Service, Mass Eye and Ear, 243 Charles Street., Boston, MA, 02114, USA.
Jain P; Ocular Melanoma Center, Retina Service, Mass Eye and Ear, 243 Charles Street., Boston, MA, 02114, USA.
Kim IK; Ocular Melanoma Center, Retina Service, Mass Eye and Ear, 243 Charles Street., Boston, MA, 02114, USA.
Gragoudas ES; Ocular Melanoma Center, Retina Service, Mass Eye and Ear, 243 Charles Street., Boston, MA, 02114, USA. .
Pokaż więcej
Źródło :
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2019 Jun; Vol. 257 (6), pp. 1319-1324. Date of Electronic Publication: 2019 Mar 27.
Typ publikacji :
Journal Article
MeSH Terms :
Conservative Treatment/*methods
Iris/*pathology
Iris Neoplasms/*radiotherapy
Melanoma/*radiotherapy
Proton Therapy/*methods
Uveal Neoplasms/*radiotherapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Female ; Follow-Up Studies ; Humans ; Iris Neoplasms/diagnosis ; Iris Neoplasms/mortality ; Male ; Melanoma/diagnosis ; Melanoma/mortality ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Survival Rate/trends ; Time Factors ; United States/epidemiology ; Uveal Neoplasms/diagnosis ; Uveal Neoplasms/mortality ; Young Adult
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
Autorzy :
Lane AM; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear Infirmary, Boston.
Kim IK; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear Infirmary, Boston.
Gragoudas ES; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear Infirmary, Boston.
Pokaż więcej
Źródło :
JAMA ophthalmology [JAMA Ophthalmol] 2018 Sep 01; Vol. 136 (9), pp. 981-986.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Liver Neoplasms/*mortality
Melanoma/*mortality
Uveal Neoplasms/*mortality
Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Female ; Follow-Up Studies ; Humans ; Immunotherapy ; Kaplan-Meier Estimate ; Liver Neoplasms/secondary ; Liver Neoplasms/therapy ; Male ; Melanoma/secondary ; Melanoma/therapy ; Middle Aged ; Ophthalmologic Surgical Procedures ; Radiotherapy ; Survival Rate ; Treatment Outcome ; Uveal Neoplasms/pathology ; Uveal Neoplasms/therapy
Czasopismo naukowe
Tytuł :
Genetic Risk Factors for Radiation Vasculopathy.
Autorzy :
Papakostas TD; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States.
Morrison MA; Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, Salt Lake City, Utah, United States.
Lane AM; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States.
Awh C; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States.
DeAngelis MM; Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, Salt Lake City, Utah, United States.
Gragoudas ES; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States.
Kim IK; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States.
Pokaż więcej
Źródło :
Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2018 Mar 01; Vol. 59 (3), pp. 1547-1553.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Polymorphism, Single Nucleotide*
Choroid Neoplasms/*radiotherapy
Melanoma/*radiotherapy
Proton Therapy/*adverse effects
Radiation Injuries/*genetics
Uveal Neoplasms/*radiotherapy
Vision Disorders/*genetics
Adult ; Aged ; Aged, 80 and over ; Female ; Genotype ; Humans ; Male ; Middle Aged ; Ocular Hypertension/complications ; Risk Factors ; Vision Disorders/etiology
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas.
Autorzy :
Papakostas TD; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Lane AM; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Morrison M; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Gragoudas ES; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Kim IK; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston.
Pokaż więcej
Źródło :
JAMA ophthalmology [JAMA Ophthalmol] 2017 Nov 01; Vol. 135 (11), pp. 1191-1196.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Forecasting*
Visual Acuity*
Choroid Neoplasms/*radiotherapy
Melanoma/*radiotherapy
Proton Therapy/*methods
Adult ; Aged ; Aged, 80 and over ; Boston/epidemiology ; Choroid Neoplasms/diagnosis ; Choroid Neoplasms/mortality ; Female ; Follow-Up Studies ; Humans ; Male ; Melanoma/diagnosis ; Melanoma/mortality ; Middle Aged ; Retrospective Studies ; Risk Factors ; Survival Rate/trends ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Systematic genomic and translational efficiency studies of uveal melanoma.
Autorzy :
Johnson CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Kim IK; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America.
Esmaeli B; Orbital Oncology and Ophthalmic Plastic Surgery Program, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Amin-Mansour A; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Treacy DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
Carter SL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Hodis E; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Seepo S; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Yu X; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Lane AM; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America.
Gragoudas ES; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America.
Vazquez F; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Nickerson E; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Cibulskis K; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
McKenna A; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America.
Gabriel SB; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Getz G; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
't Hoen PAC; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Garraway LA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Woodman SE; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2017 Jun 08; Vol. 12 (6), pp. e0178189. Date of Electronic Publication: 2017 Jun 08 (Print Publication: 2017).
Typ publikacji :
Journal Article
MeSH Terms :
Genome, Human*
Melanoma/*genetics
Protein Biosynthesis/*genetics
Uveal Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Eukaryotic Initiation Factor-1/genetics ; Female ; Humans ; Male ; Melanoma/pathology ; Middle Aged ; Mutation ; Uveal Neoplasms/pathology ; Young Adult
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma.
Autorzy :
Kim IK; Massachusetts Eye and Ear, Retina Service, Department of Ophthalmology, Harvard Medical School, Boston, MA.
Lane AM; Massachusetts Eye and Ear, Retina Service, Department of Ophthalmology, Harvard Medical School, Boston, MA.
Jain P; Massachusetts Eye and Ear, Retina Service, Department of Ophthalmology, Harvard Medical School, Boston, MA.
Awh C; Massachusetts Eye and Ear, Retina Service, Department of Ophthalmology, Harvard Medical School, Boston, MA.
Gragoudas ES; Massachusetts Eye and Ear, Retina Service, Department of Ophthalmology, Harvard Medical School, Boston, MA.
Pokaż więcej
Źródło :
Transactions of the American Ophthalmological Society [Trans Am Ophthalmol Soc] 2016 Aug; Vol. 114, pp. T2.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
MeSH Terms :
Choroid Neoplasms/*radiotherapy
Melanoma/*radiotherapy
Proton Therapy/*adverse effects
Radiation Injuries/*prevention & control
Ranibizumab/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/administration & dosage ; Choroid Neoplasms/diagnosis ; Female ; Follow-Up Studies ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies
Czasopismo naukowe
Tytuł :
Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea.
Autorzy :
Patel AV; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
Lane AM; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
Morrison MA; Department of Ophthalmology and Visual Science, University of Utah, Salt Lake City, Utah.
Trofimov AV; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Shih HA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Gragoudas ES; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
Kim IK; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło :
Ophthalmology [Ophthalmology] 2016 Feb; Vol. 123 (2), pp. 369-377. Date of Electronic Publication: 2015 Nov 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Proton Therapy*
Choroid Neoplasms/*radiotherapy
Fovea Centralis/*radiation effects
Melanoma/*radiotherapy
Visual Acuity/*physiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Choroid Neoplasms/physiopathology ; Female ; Follow-Up Studies ; Fovea Centralis/pathology ; Humans ; Male ; Melanoma/physiopathology ; Middle Aged ; Radiotherapy Dosage ; Relative Biological Effectiveness ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma--Reply.
Autorzy :
Lane AM; Retina Service, Massachusetts Eye and Ear Infirmary, Boston.
Kim IK; Retina Service, Massachusetts Eye and Ear Infirmary, Boston.
Gragoudas ES; Retina Service, Massachusetts Eye and Ear Infirmary, Boston.
Pokaż więcej
Źródło :
JAMA ophthalmology [JAMA Ophthalmol] 2016 Feb; Vol. 134 (2), pp. 239-40.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Cause of Death*
Melanoma/*mortality
Melanoma/*radiotherapy
Proton Therapy/*mortality
Uveal Neoplasms/*mortality
Uveal Neoplasms/*radiotherapy
Female ; Humans ; Male
Raport
Tytuł :
Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Autorzy :
Gupta MP; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston2Department of Ophthalmology, Weill Cornell Medical College, New York, New York.
Lane AM; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston.
DeAngelis MM; Department of Ophthalmology, University of Utah, Salt Lake City.
Mayne K; Department of Ophthalmology, University of Utah, Salt Lake City.
Crabtree M; Department of Ophthalmology, University of Utah, Salt Lake City.
Gragoudas ES; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston.
Kim IK; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston.
Pokaż więcej
Źródło :
JAMA ophthalmology [JAMA Ophthalmol] 2015 Aug; Vol. 133 (8), pp. 881-7.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Polymorphism, Single Nucleotide*
Germ-Line Mutation/*genetics
Melanoma/*diagnosis
Melanoma/*genetics
Tumor Suppressor Proteins/*genetics
Ubiquitin Thiolesterase/*genetics
Uveal Neoplasms/*diagnosis
Uveal Neoplasms/*genetics
Female ; Humans ; Male ; Middle Aged ; Phenotype ; Polymerase Chain Reaction ; Retrospective Studies ; Sequence Analysis, DNA ; Visual Acuity
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Autorzy :
Lane AM; Retina Service, Massachusetts Eye and Ear Infirmary, Boston.
Kim IK; Retina Service, Massachusetts Eye and Ear Infirmary, Boston.
Gragoudas ES; Retina Service, Massachusetts Eye and Ear Infirmary, Boston.
Pokaż więcej
Źródło :
JAMA ophthalmology [JAMA Ophthalmol] 2015 Jul; Vol. 133 (7), pp. 792-6.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cause of Death*
Melanoma/*mortality
Melanoma/*radiotherapy
Proton Therapy/*mortality
Uveal Neoplasms/*mortality
Uveal Neoplasms/*radiotherapy
Age Distribution ; Aged ; Cohort Studies ; Confidence Intervals ; Databases, Factual ; Disease-Free Survival ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Melanoma/pathology ; Middle Aged ; Neoplasm Invasiveness/pathology ; Neoplasm Staging ; Odds Ratio ; Prognosis ; Proton Therapy/methods ; Retrospective Studies ; Risk Assessment ; Sex Distribution ; Survival Analysis ; Time ; United States ; Uveal Neoplasms/pathology
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Autorzy :
Njauw CN; Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Kim I
Piris A
Gabree M
Taylor M
Lane AM
DeAngelis MM
Gragoudas E
Duncan LM
Tsao H
Pokaż więcej
Źródło :
PloS one [PLoS One] 2012; Vol. 7 (4), pp. e35295. Date of Electronic Publication: 2012 Apr 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Germ-Line Mutation*
Eye Neoplasms/*genetics
Melanoma/*genetics
Neoplasm Metastasis/*genetics
Skin Neoplasms/*genetics
Tumor Suppressor Proteins/*genetics
Ubiquitin Thiolesterase/*genetics
Adult ; Cohort Studies ; Eye/metabolism ; Eye/pathology ; Eye Neoplasms/pathology ; Female ; Genetic Predisposition to Disease ; Humans ; Male ; Melanoma/pathology ; Middle Aged ; Pedigree ; Skin/metabolism ; Skin/pathology ; Skin Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Proton irradiation for peripapillary and parapapillary melanomas.
Autorzy :
Lane AM; Retina Service, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA. />Kim IK
Gragoudas ES
Pokaż więcej
Źródło :
Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2011 Sep; Vol. 129 (9), pp. 1127-30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Proton Therapy*
Melanoma/*radiotherapy
Optic Disk/*radiation effects
Optic Nerve Neoplasms/*radiotherapy
Retinal Neoplasms/*radiotherapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Eye Enucleation ; Humans ; Melanoma/mortality ; Melanoma/pathology ; Middle Aged ; Optic Nerve Neoplasms/mortality ; Optic Nerve Neoplasms/pathology ; Retinal Neoplasms/mortality ; Retinal Neoplasms/pathology ; Survival Rate ; Treatment Outcome ; Visual Acuity/physiology ; Young Adult
Czasopismo naukowe
Tytuł :
Posterior uveal melanoma in young patients treated with proton beam therapy.
Autorzy :
Vavvas D; Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02131, USA. />Kim I
Lane AM
Chaglassian A
Mukai S
Gragoudas E
Pokaż więcej
Źródło :
Retina (Philadelphia, Pa.) [Retina] 2010 Sep; Vol. 30 (8), pp. 1267-71.
Typ publikacji :
Journal Article
MeSH Terms :
Radiotherapy, High-Energy*
Melanoma/*radiotherapy
Uveal Neoplasms/*radiotherapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Child ; Female ; Follow-Up Studies ; Humans ; Male ; Melanoma/mortality ; Melanoma/pathology ; Middle Aged ; Prognosis ; Protons ; Retrospective Studies ; Survival Rate ; Uveal Neoplasms/mortality ; Uveal Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Mortality after diagnosis of small melanocytic lesions of the choroid.
Autorzy :
Lane AM; Massachusetts Eye and Ear Infirmary, Boston, USA. />Egan KM
Kim IK
Gragoudas ES
Pokaż więcej
Źródło :
Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2010 Aug; Vol. 128 (8), pp. 996-1000.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Choroid Neoplasms/*mortality
Melanoma/*mortality
Nevus, Pigmented/*mortality
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cause of Death ; Child ; Child, Preschool ; Choroid Neoplasms/diagnosis ; Choroid Neoplasms/radiotherapy ; Female ; Humans ; Male ; Melanoma/diagnosis ; Melanoma/radiotherapy ; Middle Aged ; Nevus, Pigmented/diagnosis ; Nevus, Pigmented/radiotherapy ; Risk Assessment ; Skin Neoplasms/diagnosis ; Skin Neoplasms/mortality ; Survival Rate ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma.
Autorzy :
Kim IK; Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114, USA. />Lane AM
Egan KM
Munzenrider J
Gragoudas ES
Pokaż więcej
Źródło :
Ophthalmology [Ophthalmology] 2010 Aug; Vol. 117 (8), pp. 1617-22. Date of Electronic Publication: 2010 Apr 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Choroid Neoplasms/*radiotherapy
Melanoma/*radiotherapy
Optic Disk/*radiation effects
Optic Nerve Diseases/*etiology
Radiation Injuries/*etiology
Radiotherapy, High-Energy/*adverse effects
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Optic Nerve Diseases/physiopathology ; Radiotherapy Dosage ; Retrospective Studies ; Vision Disorders/physiopathology ; Visual Acuity ; Young Adult
Czasopismo naukowe
Tytuł :
Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
Autorzy :
Kim IK; Retina Service, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA. />Lane AM
Gragoudas ES
Pokaż więcej
Źródło :
Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2010 Jul; Vol. 128 (7), pp. 871-5.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Liver Neoplasms/*mortality
Liver Neoplasms/*secondary
Melanoma/*mortality
Melanoma/*secondary
Uveal Neoplasms/*mortality
Uveal Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Cause of Death ; Female ; Humans ; Liver Function Tests ; Male ; Melanoma/radiotherapy ; Middle Aged ; Neoplasm Staging ; Prognosis ; Radiotherapy, High-Energy ; Retrospective Studies ; Survival Rate ; Tomography, X-Ray Computed ; Uveal Neoplasms/radiotherapy
Czasopismo naukowe
Tytuł :
Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis.
Autorzy :
Lane AM; Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114, USA. />Egan KM
Harmon D
Holbrook A
Munzenrider JE
Gragoudas ES
Pokaż więcej
Źródło :
Ophthalmology [Ophthalmology] 2009 Nov; Vol. 116 (11), pp. 2206-12. Date of Electronic Publication: 2009 Sep 10.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Interferon-alpha/*therapeutic use
Melanoma/*drug therapy
Uveal Neoplasms/*drug therapy
Antineoplastic Agents/adverse effects ; Chemotherapy, Adjuvant ; Eye Enucleation ; Female ; Humans ; Interferon alpha-2 ; Interferon-alpha/adverse effects ; Male ; Melanoma/mortality ; Middle Aged ; Neoplasm Metastasis ; Radiotherapy, Adjuvant ; Recombinant Proteins ; Risk Factors ; Survival Rate ; Treatment Outcome ; Uveal Neoplasms/mortality
Czasopismo naukowe
Tytuł :
Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Autorzy :
Marucci L; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.
Lane AM
Li W
Egan KM
Gragoudas ES
Adams JA
Collier JM
Munzenrider JE
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2006 Mar 15; Vol. 64 (4), pp. 1018-22. Date of Electronic Publication: 2006 Jan 10.
Typ publikacji :
Journal Article
MeSH Terms :
Proton Therapy*
Melanoma/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Uveal Neoplasms/*radiotherapy
Adult ; Aged ; Aged, 80 and over ; Confidence Intervals ; Eye Enucleation ; Female ; Follow-Up Studies ; Humans ; Male ; Melanoma/surgery ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Radiotherapy, Conformal ; Retrospective Studies ; Treatment Outcome ; Uveal Neoplasms/pathology ; Uveal Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Evidence-based estimates of outcome in patients irradiated for intraocular melanoma.
Autorzy :
Gragoudas E; Retina Service, Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114, USA. />Li W
Goitein M
Lane AM
Munzenrider JE
Egan KM
Pokaż więcej
Źródło :
Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2002 Dec; Vol. 120 (12), pp. 1665-71.
Typ publikacji :
Journal Article
MeSH Terms :
Melanoma/*radiotherapy
Uveal Neoplasms/*radiotherapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Eye Enucleation ; Female ; Follow-Up Studies ; Humans ; Likelihood Functions ; Male ; Melanoma/mortality ; Melanoma/pathology ; Middle Aged ; Neoplasm Recurrence, Local ; Prognosis ; Risk Factors ; Uveal Neoplasms/mortality ; Uveal Neoplasms/pathology ; Visual Acuity
Czasopismo naukowe
Tytuł :
Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
Autorzy :
Gragoudas ES; Clinical Research Unit, Retina Service, Massachusetts Eye and Ear Infirmary, Boston, USA.
Lane AM
Munzenrider J
Egan KM
Li W
Pokaż więcej
Źródło :
Transactions of the American Ophthalmological Society [Trans Am Ophthalmol Soc] 2002; Vol. 100, pp. 43-8; discussion 48-9.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Choroid Neoplasms/*radiotherapy
Ciliary Body/*radiation effects
Melanoma/*radiotherapy
Uveal Neoplasms/*radiotherapy
Choroid Neoplasms/mortality ; Choroid Neoplasms/pathology ; Ciliary Body/pathology ; Female ; Follow-Up Studies ; Humans ; Male ; Melanoma/mortality ; Melanoma/pathology ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Protons ; Radiotherapy, High-Energy ; Risk Factors ; Survival Rate ; Treatment Failure ; Uveal Neoplasms/mortality ; Uveal Neoplasms/pathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies